Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.13 USD | -0.27% | -3.88% | -51.80% |
08/05 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
08/05 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.80% | 581M | |
+37.67% | 727B | |
-7.95% | 354B | |
+15.72% | 328B | |
-0.48% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.74% | 164B | |
-2.12% | 164B |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- Transcript : EyePoint Pharmaceuticals, Inc. - Special Call